StonvexLoading…
StonvexCore line items from CLSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2021 2021-03-31 | Q4 2020 2020-12-31 | Annual 2020 2020-09-30 | Q2 2020 2020-06-30 |
|---|---|---|---|---|---|
Revenue | $164.49M | $1.98M | $1.09M | $8.62M | $7.27M |
Operating Income | Not available | $-8.67M | $-6.17M | $-15.14M | $-7.41M |
Net Income | Not available | $7.40M | $-7.17M | $-23.35M | $-16.28M |
EPS (Diluted) | $-0.20 | $0.00 | $-0.32 | Not available | $-2.32 |
Total Assets | Not available | $292.61M | $78.17M | $22.34M | $20.63M |
Total Liabilities | Not available | $8.89M | $6.14M | $5.91M | $2.27M |
Cash & Equivalents | Not available | $157.27M | $25.63M | $3.13M | $1.96M |
Free Cash Flow OCF − CapEx | Not available | $-20.74M | $-6.85M | $-6.68M | $-3.71M |
Shares Outstanding | Not available | 33.87M | 24.07M | 17.39M | 16.12M |